InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,476.00
(
1.10%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
77.97
(
0.00%
)
Bitcoin
61,842.46
(
-0.37%
)
Post# of 6280
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Gd2Aussie3

Send PM Follow Ignore
Followers 4
Posts 1030
Boards Moderated 1
Alias Born 06/04/2004

Gd2Aussie3

Re: None

Thursday, 04/19/2007 9:33:08 PM

Thursday, April 19, 2007 9:33:08 PM

Post# of 6280
No surprise so far. I did state in post #816:

"I have followed Avanir since 1999 and have purchased stocks and options (puts & calls) and I guaranteed it will go back down and maybe even lower than your $3 to around $2.50.

The FDA still hasn't said "bo!" yet. Avanir shareholders know from Abreva and Neurodex how important the FDA is. Until Avanir submits to them for approval, the stock will rock back and forth. It'll be to traders advantage to watch the swings."

Didn't take long for the swings. More to come.

G' day Mates,

Aussie

Australia is a beautiful place with wonderful people that just love Americans. You've got to go there some day. Give it a go Mate.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up